Literature DB >> 8451610

First person account: the onset of paranoia.

W D Bowden.   

Abstract

The article that follows is part of the Schizophrenia Bulletin's ongoing First Person Accounts series. We hope that mental health professionals--the Bulletin's primary audience--will take this opportunity to learn about the issues and difficulties confronted by consumers of mental health care. In addition, we hope that these accounts will give patients and families a better sense of not being alone in confronting the problems that can be anticipated by persons with serious emotional difficulties. We welcome other contributions from patients, ex-patients, or family members. Our major editorial requirement is that such contributions be clearly written and organized, and that a novel or unique aspect of schizophrenia be described, with special emphasis on points that will be important for professionals. Clinicians who see articulate patients, with experiences they believe should be shared, might encourage these patients to submit their articles to First Person Accounts, Division of Clinical and Treatment Research, NIMH, 5600 Fishers Lane, Rm. 18C-06, Rockville, MD 20857.--The Editors.

Entities:  

Mesh:

Year:  1993        PMID: 8451610     DOI: 10.1093/schbul/19.1.165

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  1 in total

1.  The lived experience of psychosis: a bottom-up review co-written by experts by experience and academics.

Authors:  Paolo Fusar-Poli; Andrés Estradé; Giovanni Stanghellini; Jemma Venables; Juliana Onwumere; Guilherme Messas; Lorenzo Gilardi; Barnaby Nelson; Vikram Patel; Ilaria Bonoldi; Massimiliano Aragona; Ana Cabrera; Joseba Rico; Arif Hoque; Jummy Otaiku; Nicholas Hunter; Melissa G Tamelini; Luca F Maschião; Mariana Cardoso Puchivailo; Valter L Piedade; Péter Kéri; Lily Kpodo; Charlene Sunkel; Jianan Bao; David Shiers; Elizabeth Kuipers; Celso Arango; Mario Maj
Journal:  World Psychiatry       Date:  2022-06       Impact factor: 79.683

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.